| 2025 | 2024 | 2023 | 2022 | 2021 | 2019 | 2018 | 2017 | 2016 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | -16,1 k € | +8.1% | -17,5 k € | +60.8% | -44,6 k € | -40.1% | -31,9 k € | -193.0% | 34,2 k € | -74.8% | 135,6 k € | +33.2% | 101,9 k € | -34.6% | 155,8 k € | -1.4% | 158,0 k € | |
| EBITDA | -17,9 k € | +3.3% | -18,5 k € | +59.5% | -45,6 k € | -39.1% | -32,8 k € | -198.0% | 33,4 k € | -75.0% | 133,5 k € | +33.4% | 100,1 k € | -35.6% | 155,4 k € | -0.1% | 155,5 k € | |
| Operating profit | -18,0 k € | +3.0% | -18,6 k € | +59.4% | -45,7 k € | -39.0% | -32,9 k € | -198.8% | 33,3 k € | -74.0% | 128,2 k € | +35.3% | 94,8 k € | -36.8% | 150,1 k € | +0.6% | 149,1 k € | |
| Profit/loss | -16,2 k € | +13.5% | -18,7 k € | +59.3% | -46,0 k € | -38.9% | -33,1 k € | -229.0% | 25,7 k € | -73.4% | 96,4 k € | +48.5% | 64,9 k € | -35.6% | 100,8 k € | +6.3% | 94,8 k € | |
| Equity | 200,0 k € | -30.4% | 287,1 k € | -21.3% | 364,9 k € | -22.3% | 469,8 k € | -5.4% | 496,7 k € | +34.5% | 369,3 k € | +35.3% | 272,9 k € | +31.2% | 208,0 k € | +94.0% | 107,2 k € | |
| Total assets | 277,1 k € | -20.4% | 348,0 k € | -18.5% | 427,2 k € | -11.8% | 484,2 k € | -4.4% | 506,3 k € | +20.1% | 421,5 k € | +26.1% | 334,2 k € | +15.9% | 288,4 k € | +46.4% | 196,9 k € | |
| Cash | 113,5 k € | -59.9% | 283,0 k € | -21.6% | 361,1 k € | -22.0% | 463,1 k € | -7.5% | 500,9 k € | +36.2% | 367,6 k € | +25.7% | 292,6 k € | +32.4% | 221,0 k € | +53.0% | 144,4 k € | |
| Debts | 77,2 k € | +26.8% | 60,9 k € | -2.4% | 62,3 k € | +334.1% | 14,4 k € | +49.7% | 9,6 k € | -81.6% | 52,2 k € | -14.9% | 61,3 k € | -23.7% | 80,4 k € | -10.4% | 89,7 k € | |
Source: Belgian Official Gazette
Private limited company · Wavre · incorporated on 30/06/2015
Private limited company loss-making in the latest fiscal year. Cash position declining (-59.9%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
PHARMA MANAGEMENT CONSULTING is a Private limited company incorporated in 2015. Its main activity is: Other professional, scientific and technical activities n.e.c.. Its registered office is in Wavre.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.